Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Acute Lymphoblastic Leukemia | Case report

Successful treatment of pulmonary haemorrhage and acute respiratory distress syndrome caused by fulminant Stenotrophomonas maltophilia respiratory infection in a patient with acute lymphoblastic leukaemia – case report

Authors: Stefan Andrei, Alexandra Ghiaur, Lavinia Brezeanu, Cristina Martac, Andreea Nicolau, Daniel Coriu, Gabriela Droc

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Stenotrophomonas maltophilia-induced pulmonary haemorrhage is considered a fatal infection among haematological patients. The outcome can be explained by the patients’ immunity status and late diagnosis and treatment.

Case presentation

We present the rare case of successful outcome in a 61-year-old female who developed alveolar haemorrhage and acute respiratory distress syndrome 8 days after a chemotherapy session for her acute lymphoblastic leukaemia, in the context of secondary bone marrow aplasia. Stenotrophomonas maltophilia was isolated in sputum culture. The patient benefitted from early empirical treatment with colistin followed by trimethoprim/sulfamethoxazole, according to the antibiogram. Despite a severe initial clinical presentation in need of mechanical ventilation, neuromuscular blocking agents infusion, and ventilation in prone position, the patient had a favourable outcome and was discharged from intensive care after 26 days.

Conclusions

Stenotrophomonas maltophilia severe pneumonia complicated with pulmonary haemorrhage is not always fatal in haematological patients. Empirical treatment of multidrug-resistant Stenotrophomonas maltophilia in an immunocompromised haematological patient presenting with hemoptysis should be taken into consideration.
Literature
1.
go back to reference Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41.CrossRef Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41.CrossRef
2.
go back to reference Mori M, Tsunemine H, Imada K, Ito K, Kodaka T, Takahashi T. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. Ann Hematol. 2014;93(6):901–11.CrossRef Mori M, Tsunemine H, Imada K, Ito K, Kodaka T, Takahashi T. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. Ann Hematol. 2014;93(6):901–11.CrossRef
3.
go back to reference Guzoglu N, Demirkol FN, Aliefendioglu D. Haemorrhagic pneumonia caused by Stenotrophomonas maltophilia in two newborns. J Infect Dev Ctries. 2015;9(5):533–5.CrossRef Guzoglu N, Demirkol FN, Aliefendioglu D. Haemorrhagic pneumonia caused by Stenotrophomonas maltophilia in two newborns. J Infect Dev Ctries. 2015;9(5):533–5.CrossRef
4.
go back to reference Shiratori S, Wakasa K, Okada K, Sugita J, Akizawa K, Shigematsu A, et al. Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: a single-center experience. Clin Transpl. 2014;28(6):656–61.CrossRef Shiratori S, Wakasa K, Okada K, Sugita J, Akizawa K, Shigematsu A, et al. Stenotrophomonas maltophilia infection during allogeneic hematopoietic stem cell transplantation: a single-center experience. Clin Transpl. 2014;28(6):656–61.CrossRef
5.
go back to reference Tada K, Kurosawa S, Hiramoto N, Okinaka K, Ueno N, Asakura Y, et al. Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage. Bone Marrow Transplant. 2013;48(1):74–9.CrossRef Tada K, Kurosawa S, Hiramoto N, Okinaka K, Ueno N, Asakura Y, et al. Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage. Bone Marrow Transplant. 2013;48(1):74–9.CrossRef
6.
go back to reference Rousseau A, Morcos M, Amrouche L, Foïs E, Casetta A, Rio B, et al. Lethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient. Leuk Lymphoma. 2004;45(6):1293–6.CrossRef Rousseau A, Morcos M, Amrouche L, Foïs E, Casetta A, Rio B, et al. Lethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient. Leuk Lymphoma. 2004;45(6):1293–6.CrossRef
7.
go back to reference Gutierrez C, Pravinkumar E, Balachandran D, Schneider V. Fatal hemorrhagic pneumonia: Don’t forget Stenotrophomonas maltophilia. Respir Med Case Rep. 2016;19:12–4.PubMedPubMedCentral Gutierrez C, Pravinkumar E, Balachandran D, Schneider V. Fatal hemorrhagic pneumonia: Don’t forget Stenotrophomonas maltophilia. Respir Med Case Rep. 2016;19:12–4.PubMedPubMedCentral
8.
go back to reference Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, et al. Clinical characteristics of rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia. Intern Med. 2020;59(2):193–8.CrossRef Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, et al. Clinical characteristics of rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia. Intern Med. 2020;59(2):193–8.CrossRef
9.
go back to reference Al-Anazi KA, Al-Jasser AM. Infections caused by Stenotrophomonas maltophilia in recipients of hematopoietic stem cell transplantation. Front Oncol. 2014;4:232.PubMedPubMedCentral Al-Anazi KA, Al-Jasser AM. Infections caused by Stenotrophomonas maltophilia in recipients of hematopoietic stem cell transplantation. Front Oncol. 2014;4:232.PubMedPubMedCentral
10.
go back to reference Gajdacs M, Urban E. Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot. Health Serv Res Manag Epidemiol. 2019;6:1–9. Gajdacs M, Urban E. Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in respiratory tract samples: a 10-year epidemiological snapshot. Health Serv Res Manag Epidemiol. 2019;6:1–9.
11.
go back to reference Mokart D, van Craenenbroeck T, Lambert J, Textoris J, Brun JP, Sannini A, et al. Prognosis of acute respiratory distress syndrome in neutropenic cancer patients. Eur Respir J. 2012;40:169–76.CrossRef Mokart D, van Craenenbroeck T, Lambert J, Textoris J, Brun JP, Sannini A, et al. Prognosis of acute respiratory distress syndrome in neutropenic cancer patients. Eur Respir J. 2012;40:169–76.CrossRef
12.
go back to reference Lemiale V, Pons S, Mirouse A, Tudesq JJ, Hourmant Y, Mokart D, et al. Sepsis and SepticShock in Patients WithMalignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study. Crit Care Med. 2020;48(6):822–9.CrossRef Lemiale V, Pons S, Mirouse A, Tudesq JJ, Hourmant Y, Mokart D, et al. Sepsis and SepticShock in Patients WithMalignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study. Crit Care Med. 2020;48(6):822–9.CrossRef
13.
go back to reference Darmon M, Azoulay E, Alberti C. FieuxF, Moreau D, Le gall JR, et al. impact of neutropenia duration on short-term mortality in Neutropenic critically ill Cancer patients. Intensive Care Med. 2002;28(12):1775–80.CrossRef Darmon M, Azoulay E, Alberti C. FieuxF, Moreau D, Le gall JR, et al. impact of neutropenia duration on short-term mortality in Neutropenic critically ill Cancer patients. Intensive Care Med. 2002;28(12):1775–80.CrossRef
Metadata
Title
Successful treatment of pulmonary haemorrhage and acute respiratory distress syndrome caused by fulminant Stenotrophomonas maltophilia respiratory infection in a patient with acute lymphoblastic leukaemia – case report
Authors
Stefan Andrei
Alexandra Ghiaur
Lavinia Brezeanu
Cristina Martac
Andreea Nicolau
Daniel Coriu
Gabriela Droc
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05378-9

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.